Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics

Patients with breast cancer are prone to SARS-CoV-2 infection [the causative virus of coronavirus disease (COVID-19)] due to their lack of immunity. In the current study, we examined the mechanism of action of Diosmetin, a flavonoid with anti-inflammatory properties, in patients with BRCA infected w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jin, Ma, Shanbo, Li, Long, Chen, Yuhan, Yang, Qian, Wang, Feiyan, Zheng, Meiling, Miao, Shan, Shi, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433109/
https://www.ncbi.nlm.nih.gov/pubmed/36060002
http://dx.doi.org/10.3389/fphar.2022.983821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433109/
https://www.ncbi.nlm.nih.gov/pubmed/36060002
http://dx.doi.org/10.3389/fphar.2022.983821

Ejemplares similares